News Headlines Article

New CIRM payouts target muscular dystrophy, ALS, Huntington’s Disease
San Francisco Business Times

Researchers from the Gladstone Institutes, Stanford University and a small Peninsula company were among those winning cash Wednesday from California’s stem cell research funding agency that could lead to therapies for Lou Gehrig’s disease, muscular dystrophy and Huntington’s Disease In all, the board overseeing the California Institute for Regenerative Medicine approved almost $41 million in funding to help researchers at eight colleges or research universities and one company to translate basic discoveries into potential stem cell therapies.